278 related articles for article (PubMed ID: 16783814)
1. Cannabis and neurodevelopment: implications for psychiatric disorders.
Sundram S
Hum Psychopharmacol; 2006 Jun; 21(4):245-54. PubMed ID: 16783814
[TBL] [Abstract][Full Text] [Related]
2. Cannabis and psychiatric disorders: it is not only addiction.
Leweke FM; Koethe D
Addict Biol; 2008 Jun; 13(2):264-75. PubMed ID: 18482435
[TBL] [Abstract][Full Text] [Related]
3. Cannabis and the developing brain: insights from behavior.
Trezza V; Cuomo V; Vanderschuren LJ
Eur J Pharmacol; 2008 May; 585(2-3):441-52. PubMed ID: 18413273
[TBL] [Abstract][Full Text] [Related]
4. Developmental exposure to cannabinoids causes subtle and enduring neurofunctional alterations.
Campolongo P; Trezza V; Palmery M; Trabace L; Cuomo V
Int Rev Neurobiol; 2009; 85():117-33. PubMed ID: 19607965
[TBL] [Abstract][Full Text] [Related]
5. Puberty as a highly vulnerable developmental period for the consequences of cannabis exposure.
Schneider M
Addict Biol; 2008 Jun; 13(2):253-63. PubMed ID: 18482434
[TBL] [Abstract][Full Text] [Related]
6. Cannabis, cannabinoids and schizophrenia: integration of the evidence.
Cohen M; Solowij N; Carr V
Aust N Z J Psychiatry; 2008 May; 42(5):357-68. PubMed ID: 18473254
[TBL] [Abstract][Full Text] [Related]
7. Endocannabinoids in cognition and dependence.
Lichtman AH; Varvel SA; Martin BR
Prostaglandins Leukot Essent Fatty Acids; 2002; 66(2-3):269-85. PubMed ID: 12052042
[TBL] [Abstract][Full Text] [Related]
8. Cannabis use and psychiatric and cogitive disorders: the chicken or the egg?
Di Forti M; Morrison PD; Butt A; Murray RM
Curr Opin Psychiatry; 2007 May; 20(3):228-34. PubMed ID: 17415074
[TBL] [Abstract][Full Text] [Related]
9. The endocannabinoid system as a target for novel anxiolytic and antidepressant drugs.
Gaetani S; Dipasquale P; Romano A; Righetti L; Cassano T; Piomelli D; Cuomo V
Int Rev Neurobiol; 2009; 85():57-72. PubMed ID: 19607961
[TBL] [Abstract][Full Text] [Related]
10. Maternal smoking, drinking or cannabis use during pregnancy and neurobehavioral and cognitive functioning in human offspring.
Huizink AC; Mulder EJ
Neurosci Biobehav Rev; 2006; 30(1):24-41. PubMed ID: 16095697
[TBL] [Abstract][Full Text] [Related]
11. The endocannabinoid system in critical neurodevelopmental periods: sex differences and neuropsychiatric implications.
Viveros MP; Llorente R; Suarez J; Llorente-Berzal A; López-Gallardo M; de Fonseca FR
J Psychopharmacol; 2012 Jan; 26(1):164-76. PubMed ID: 21669929
[TBL] [Abstract][Full Text] [Related]
12. Adolescent exposure to cannabis as a risk factor for psychiatric disorders.
Rubino T; Zamberletti E; Parolaro D
J Psychopharmacol; 2012 Jan; 26(1):177-88. PubMed ID: 21768160
[TBL] [Abstract][Full Text] [Related]
13. Nicotine and cannabinoids: parallels, contrasts and interactions.
Viveros MP; Marco EM; File SE
Neurosci Biobehav Rev; 2006; 30(8):1161-81. PubMed ID: 17049986
[TBL] [Abstract][Full Text] [Related]
14. Adolescent brain maturation, the endogenous cannabinoid system and the neurobiology of cannabis-induced schizophrenia.
Bossong MG; Niesink RJ
Prog Neurobiol; 2010 Nov; 92(3):370-85. PubMed ID: 20624444
[TBL] [Abstract][Full Text] [Related]
15. The endocannabinoid system during development: emphasis on perinatal events and delayed effects.
Fride E; Gobshtis N; Dahan H; Weller A; Giuffrida A; Ben-Shabat S
Vitam Horm; 2009; 81():139-58. PubMed ID: 19647111
[TBL] [Abstract][Full Text] [Related]
16. [Cognitive and psychotic effects after cessation of chronic cannabis use].
van Amsterdam JG; van der Laan JW; Slangen JL
Ned Tijdschr Geneeskd; 1998 Mar; 142(10):504-8. PubMed ID: 9623095
[TBL] [Abstract][Full Text] [Related]
17. Regional brain abnormalities associated with long-term heavy cannabis use.
Yücel M; Solowij N; Respondek C; Whittle S; Fornito A; Pantelis C; Lubman DI
Arch Gen Psychiatry; 2008 Jun; 65(6):694-701. PubMed ID: 18519827
[TBL] [Abstract][Full Text] [Related]
18. Cannabinoid exposure: effects on development.
Dalterio SL
Neurobehav Toxicol Teratol; 1986; 8(4):345-52. PubMed ID: 3531903
[TBL] [Abstract][Full Text] [Related]
19. Neuronal substrates and functional consequences of prenatal cannabis exposure.
Calvigioni D; Hurd YL; Harkany T; Keimpema E
Eur Child Adolesc Psychiatry; 2014 Oct; 23(10):931-41. PubMed ID: 24793873
[TBL] [Abstract][Full Text] [Related]
20. The future of cannabinoids as analgesic agents: a pharmacologic, pharmacokinetic, and pharmacodynamic overview.
McCarberg BH; Barkin RL
Am J Ther; 2007; 14(5):475-83. PubMed ID: 17890938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
